New Patient telephone follow up clinic. Introduction North Tees and Hartlepool NHS Foundation Trust treat patients across two sites. We currently administer.

Slides:



Advertisements
Similar presentations
NWLH NHS Trust Chemotherapy Lead Nurse/Matron
Advertisements

A Case Study GP Masterclass Catherine Dale, RN, BSc Cancer Care
Acute Oncology Audit Melanie Robertson Nurse Consultant - Oncology City Hospitals Sunderland.
Cancer of Unknown Primary Dr Chris Jones Consultant Medical Oncologist North of England Cancer Network Annual Conference 20 September 2013.
Dr Christopher Dalley Department of Haematology
Direct Access Flexible Sigmoidoscopy Pathway for GPs
Acute Oncology What is it?. Overview of Acute Oncology Encompasses management of patients with severe complications following the treatment of, or as.
Door to Needle Neutropenic Sepsis Audit (Macmillan Chemotherapy Unit ) May 11– October 11 Baleseng Nkolobe NWLH NHS Trust Chemotherapy Lead Nurse/Matron.
Deep Vein Thrombosis (DVT)
Outreach Partner Notification 5 years on Linda Lewis Senior Health Adviser Carlton Street Clinic 27 – 29 Carlton Street Blyth Northumberland NE24 2DT.
SIDE EFFECTS OF GUTKHA (TOBACCO) Carcinogenic The most serious side effect associated with prolonged gutkha use is an increased risk of cancer. The National.
Improving the Door to Needle time for Febrile Neutropenia Partnership working between Heart of England NHS Foundation Trust (HoEFT) and Pan Birmingham.
A Survey of Quality of Life Following Surgery for Malignant Pleural Mesothelioma: Reflects the patients’ commitment to Learning about the Disease D A Raffle,
Upper gastrointestinal cancers
Acute Oncology Service (Insert relevant service name)
Breast Cancer Surgery Challenging Preconceptions Hamish Brown Consultant Breast and General Surgeon Sandwell and West Birmingham Hospitals NHS Trust
Breast cancer patient pathway
PRO-CTCAE Task 8 Committee: Feasibility Research March 18 th 2011 (11am EST) Kickoff Telecon.
GP Perspectives on the Home Based Crisis Team. City North Sectors, Cork. Muller Neff, D., O’Brien S.M. ABSTRACT: OBJECTIVES: The introduction of crisis.
Introduction The treatment of relapsed ovarian cancer involves rechallenge with platinum based chemotherapy. One regimen commonly in use at the Christie.
The Acute Oncology Project
Acute Oncology Assessment Service From Birth to Infancy: Out reach Service In reach Service Outliers.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
JCUH NICE MSCC Guidelines Compliance audit Ruth Mhlanga Senior Specialist Physiotherapist Oncology and Haematology.
Low-molecular-weight heparin (LMWH) use in an oncological setting Emma Lowe, Melanie Lowe, Hilary Oldham, Joan Karasu. Clinical service technicians, Pharmacy.
Chemotherapy Audit  Audit of patients who died within three months of their last dose of chemotherapy at Airedale General Hospital  The records of 50.
Analysis of Patient Experience of Cancer Care Pathway within Merseyside & Cheshire Produced by Merseyside and Cheshire Cancer Network Presented: November.
Acute Oncology Dr Nicola Storey.
BILBOROUGH AND ASSARTS FARM MEDICAL CENTRE PATIENT SURVEY 2013.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.
Introduction The NHS in England is estimated to be responsible for the emission of approximately 21 million tonnes of carbon dioxide equivalents per annum.
Newcastle upon Tyne Hospitals NHS Foundation Trust Audit results for NAOG meeting 19 April 2013 The Newcastle upon Tyne Hospitals NHS Foundation Trust.
Acknowledgements Staff and patients from Teenage Cancer Trust, NHSGGC. Conclusion We are the first to design an NHS patient app in GGC. We consider this.
Brentuximab Vedotin Administered Concurrently with Multi-Agent Chemotherapy as Frontline Treatment of ALCL and Other CD30-Positive Mature T-Cell and NK-Cell.
Crisis Care: A partnership approach Maqsood Ahmad Strategic Clinical Networks Manager Mental Health, Dementia and End of Life Care Constable Adele Owen.
The Christie NHS Foundation Trust Supporting the patient and accessing support services Suzanne Mc Keever Nurse Specialist Psycho-Oncology.
Acute Oncology in Northumbria Healthcare NHS Trust Dr. Ian Neilly, Acute Oncology Clinical Lead.
National Cancer Survivorship Initiative 2010 Update.
T. Hijal MD, A. Al Hamad MD, N. Khalaf, K. Sultanem MD, S. Faria MD and T. Muanza MD McGill University, Department of Radiation Oncology, Montréal, Québec,
Research into Practice Audiology Chemotherapy Ototoxicity Project.
NHS West Kent Clinical Commissioning Group West Kent Urgent Care DRAFT Strategy Delivering a safe and sustainable urgent care system by
Pharmacy Technician led chemotherapy education and toxicity assessment service: Oral Vinorelbine Sarah Goman Susan Edwards Carys Weale Bethan Tranter.
A Renal Advice Service: Audit of a 5 year service Steve Dickinson, Paul Johnston, Jon Stratton, Rob Parry Renal Consultants, Renal Department, Royal.
The Symptom Study Overview Cohort study with nested qualitative study Set in 2 University centres: Cambridge & Durham Aim to recruit 200 cases with each.
Dr Michelle Webb Renal Consultant, Associate Medical Director Patient Safety, East Kent Hospitals University NHS Foundation Trust and Co-lead for Sepsis.
Determining Preferences for Symptom Management Assistance For Those with Oral Anti-Cancer Treatment Sandra L. Spoelstra, PhD, RN GSA Annual Meeting New.
ACCESS TO PALLIATIVE CARE FOR UPPER GI CANCER PATIENTS A SURVEY OF 5 CANCER NETWORKS DR Bailey 1 C Wood 2 and M Goodman 3.
NCSI CYP Manchester Pilots Dr Ed Smith. Background Brief Summary Steering Group (Paed, TYA and Adult, GP, CC/SOC) Building on work at RMCH & Christie.
Step 5 workshop. Step 5 - Plan Recognising when an individual enters the dying phase Appropriate and inappropriate hospital admissions at end of life.
The Enhanced Continence Project – In Practice Tina Bryant – Operations Manager Sarah Thompson – Community Nurse Specialist.
Breast Cancer Treatment. Treatment 2 aspects 1. Treatment of the breast itself: “Local Treatment” 2. Treatment of the whole body = “Systemic treatment”
Within the Cancer Program in MUH doing the best research and providing the best care to our patients. This is the best cancer care hospital.cancer care.
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
Transforming Aftercare Pathways: Your Voice
Screening for Life 2017.
Hypothermia for Preventing Chemotherapy-Induced Peripheral Neuropathy
Patient’s experiences of anticancer therapy and opportunities for community pharmacists to support patients with cancer. Fiona MacLean1, Alexander Mullen2,
The ‘5C’ Walk-In Clinic:
Dr Alison Giles Palliative Medicine Consultant
Velindre Cancer Centre
Wednesday 7 June – Tuesday 13 June
Chemotherapy Services in England: Ensuring quality and safety
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Recognising sepsis and taking action
National Cancer Patient Experience (NCPES) Results 2017
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Sian Middleton, Lead Nurse for Cancer, Gloucestershire Hospitals.
Breath Testing for Gastrointestinal Disease
Living with Ovarian Cancer: How Palliative Care Can Help
Presentation transcript:

New Patient telephone follow up clinic

Introduction North Tees and Hartlepool NHS Foundation Trust treat patients across two sites. We currently administer chemotherapy to patients with a diagnosis of breast, bowel, lung, bladder, prostate and haematological cancer. We are constantly looking at ways to improve our service for these patient.

Aim of clinic Early identification of chemotherapy related toxicity Prompt advice and intervention Improve patient support and experience Reduce attendance/admission to hospital

Client group Patients who have received their first dose of chemotherapy Patients who have received chemotherapy previously and have commenced on a new treatment regime

Timing of call Patients on highly emetic chemotherapy regimes contacted within 48 hours Patients on regimes known to cause diarrhoea contacted on day 5 or nearest working day Patients identified by their oncologist as vulnerable contacted within the first week of their treatment All other patients contacted at 7 days

Assessment All patients were assessed using the 24 hour assessment tool Patients were given a satisfaction questionnaire when they attended for the next cycle of treatment

sample Patients contacted in July and August 62 patients eligible for call 10 patients were not contactable

Toxicities 14 patients reported no undue toxicity 2 Peripheral neuropathy 2 Diarrhoea 9 Constipation 8 Nausea and Vomiting 4 Poor appetite 3 Sore Mouth 3 Lethargy 3 Pain 2 Insomnia 1 Sepsis 1 Other (DVT)

Interventions All patients received telephone advice and support 3 received a prescription or patient group directive 2 received GP review 2 attended for hospital review 1 Admission

Conclusion Probably too early to tell Time consuming particularly when patients were not contactable However over half of the patients needed some degree of intervention Patients who replied to questionnaire expressed appreciation of service and support offered